Refractory B-Cell Non-Hodgkin Lymphoma
Showing 26 - 32 of 32
Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Hodgkin Lymphoma, Recurrent Mantle Cell Lymphoma Trial in Seattle (procedure,
Completed
- Recurrent B-Cell Non-Hodgkin Lymphoma
- +7 more
- Autologous Hematopoietic Stem Cell Transplantation
- +7 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 29, 2020
Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Hodgkin Lymphoma, Recurrent T-Cell Non-Hodgkin Lymphoma Trial in Seattle
Terminated
- Recurrent B-Cell Non-Hodgkin Lymphoma
- +5 more
- Autologous Hematopoietic Stem Cell Transplantation
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Mar 26, 2020
CD19 Positive, Mantle Cell Lymphoma, Recurrent DLBCL Trial in Houston (procedure, drug, biological)
Withdrawn
- CD19 Positive
- +6 more
- Autologous Hematopoietic Stem Cell Transplantation
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Jan 27, 2020
Relapsed B-Cell Non-Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma Trial in Worldwide (AFM11)
Terminated
- Relapsed B-Cell Non-Hodgkin Lymphoma
- Refractory B-Cell Non-Hodgkin Lymphoma
-
Boston, Massachusetts
- +8 more
Jun 17, 2019
CD20 Positive, Recurrent B-Cell Non-Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma Trial in United States (Ipilimumab,
Completed
- CD20 Positive
- +2 more
- Ipilimumab
- +2 more
-
Duarte, California
- +6 more
Apr 10, 2018
Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Indolent Adult Non-Hodgkin Lymphoma
Completed
- Recurrent B-Cell Non-Hodgkin Lymphoma
- +3 more
- Cladribine
- +3 more
-
Portland, Oregon
- +1 more
Nov 9, 2017
Relapsed/Refractory Aggressive Non Hodgkin Lymphoma Treated With
Completed
- Refractory B-Cell Non-Hodgkin Lymphoma
- Recurrent B-Cell Non-Hodgkin Lymphoma
- (no location specified)
Dec 12, 2016